Investments (Tables)

9 Months Ended

Mar. 31, 2025

Investments, Debt and Equity Securities [Abstract]

Schedule of Investments

The Company’s Investments reported in the accompanying consolidated balance sheets, consisted of the following:

	March 31, 2025		June 30, 2024
Equity method investments:
NRG	$	6,994	$	7,536
Other equity method investments	4,513		5,038
Equity investments with readily determinable fair values:
Xtract One Technologies Inc. (“Xtract One”) common stock	10,277		17,380
Other equity investments with readily determinable fair values held in trust under the Company’s Executive Deferred Compensation Plan	21,773		18,837
Equity investments without readily determinable fair values (a)	7,964		6,757
Derivative instruments:
Xtract One warrants	1,904		6,995
Total investments	$	53,425	$	62,543

_________________

(a)During the three and nine months ended March 31, 2025, the Company recorded impairment charges and reductions in carrying value resulting from observable price changes of $0 and $894, respectively, related to its equity securities without readily determinable fair values in Miscellaneous expense, net within the accompanying consolidated statements of operations. During the three and nine months ended March 31, 2024, the Company did not record any impairment charges or changes in carrying value of its equity securities without readily determinable fair values in the accompanying consolidated statements of operations.

Schedule of Debt Securities, Trading, and Equity Securities, FV-NI

The cost basis and carrying value of equity investments with readily determinable fair values are as follows:

	March 31, 2025				June 30, 2024
	Cost Basis		Carrying Value/Fair Value		Cost Basis		Carrying Value/Fair Value
Xtract One common stock	$	7,721	$	10,277	$	7,721	$	17,380
Other equity investments with readily determinable fair values	18,723		21,773		16,510		18,837
	$	26,444	$	32,050	$	24,231	$	36,217

The following table summarizes the realized and unrealized gains (losses) on equity investments with readily determinable fair values, recorded within Miscellaneous expense, net within the Company’s consolidated statements of operations, for the three and nine months ended March 31, 2025 and 2024:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2025		2024		2025		2024
Unrealized loss - Xtract One common stock	$	(3,387)	$	(853)	$	(7,103)	$	(5,645)
Unrealized (loss) gain - other equity investments with readily determinable fair values	(319)		809		723		1,501
Realized gain - other equity investments with readily determinable fair values	184		12		250		55
	$	(3,522)	$	(32)	$	(6,130)	$	(4,089)